"Moving forward, I am confident that obtaining a graduate education will empower me to improve the quality of life for others. My ultimate career goal is to become a scientist who inspires others to achieve their goals."
David Isaac Berrios
Host University: University of California, San Francisco
FOSTER CITY, Calif., Oct. 25, 2017 /3BL Media/ -- Gilead Sciences, Inc.(NASDAQ:GILD) announced the second round of recipients of its HIV cure grants program. This new commitment will provide $7.5 million to support five additional HIV cure research initiatives led by top academic institutions and focused on translational research and efficacy studies in preclinical models.
When Elisabeth Krow-Lucal started college at the University of California, San Diego in 2005, she thought, “Wouldn’t it be so cool to work in a lab that studies the bubonic plague or another infectious disease that changed the course of history?”